Drug Database
N02CC03 zolmitriptan
Approved by UK Medicines & Healthcare Products Regulatory Agency & the European Medicines Agency.
- POM Zolmitriptan 2.5 mg Film-coated Tablets
- POM Zolmitriptan 2.5 mg Orodispersible Tablets
- POM Zolmitriptan 2.5 mg, 5 mg Orodispersible tablets
- POM Zolmitriptan 2.5mg Orodispersible Tablets
- POM Zolmitriptan 5 mg Film-coated Tablets
- POM Zolmitriptan 5 mg Orodispersible Tablets
- POM Zolmitriptan 5mg Orodispersible Tablets
- POM Zolmitriptan 5mg Orodispersible Tablets
- POM Zomig 5mg Nasal Spray
- POM Zomig Rapimelt 2.5mg
- POM Zomig Rapimelt 5 mg Orodispersible Tablets
- POM Zomig Tablets 2.5mg
Learning Zones
Disclaimer
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drug Licencing
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).